Reports
Sale
Latin America In-Vitro Diagnostics Market Size, Forecast: By Product and Services: Reagents and Kits, Instruments, Software and Services; By Technology: Infectious Diseases, Clinical Chemistry, Molecular Diagnostics, Haematology, Microbiology, Others; By Application; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
Key Industry Players in the Market
The report presents a detailed analysis of the following key players in the Latin America in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffmann-La Roche Ltd
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- WAMA Diagnóstica
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Latin America In-Vitro Diagnostics Market Report Snapshots
Latin America In-Vitro Diagnostics Market Size
Latin America In-Vitro Diagnostics Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Latin America
7 Opportunities and Challenges in the Market
8 Latin America In-Vitro Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Latin America In-Vitro Diagnostics Historical Market (2017-2023)
8.3 Latin America In-Vitro Diagnostics Market Forecast (2024-2032)
8.4 Latin America In-Vitro Diagnostics Market by Product and Services
8.4.1 Reagents and Kits
8.4.1.1 Historical Trend (2017-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Instruments
8.4.2.1 Historical Trend (2017-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Software and Services
8.4.3.1 Historical Trend (2017-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 Latin America In-Vitro Diagnostics Market by Technology
8.5.1 Infectious Diseases
8.5.1.1 Historical Trend (2017-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.1.3 Breakup by Type
8.5.1.3.1 Enzyme-Linked Immunosorbent Assay (ELISA)
8.5.1.3.2 Enzyme-Linked Immunospot (ELISPOT)
8.5.1.3.3 Rapid Tests
8.5.1.3.4 Radioimmunoassay (RIA)
8.5.1.3.5 Western Blotting
8.5.1.3.6 Others
8.5.2 Clinical Chemistry
8.5.2.1 Historical Trend (2017-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.2.3 Breakup by Type
8.5.2.3.1 Basic Metabolic Panels
8.5.2.3.2 Liver Panels
8.5.2.3.3 Renal Profiles
8.5.2.3.4 Lipid Profiles
8.5.2.3.5 Thyroid Function Panels
8.5.2.3.6 Electrolyte Panels
8.5.2.3.7 Specialty Chemical Tests
8.5.2.3.8 Others
8.5.3 Molecular Diagnostics
8.5.3.1 Historical Trend (2017-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.3.3 Breakup by Type
8.5.3.3.1 Polymerize Chain Reaction (PCR)
8.5.3.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.5.3.3.3 Hybridisation
8.5.3.3.4 DNA Diagnostics
8.5.3.3.5 Microarray
8.5.3.3.6 Others
8.5.4 Haematology
8.5.4.1 Historical Trend (2017-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Microbiology
8.5.5.1 Historical Trend (2017-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Coagulation and Haemostasis
8.5.6.1 Historical Trend (2017-2023)
8.5.6.2 Forecast Trend (2024-2032)
8.5.7 Urinalysis
8.5.7.1 Historical Trend (2017-2023)
8.5.7.2 Forecast Trend (2024-2032)
8.5.8 Others
8.6 Latin America In-Vitro Diagnostics Market by Application
8.6.1 Infectious Diseases
8.6.1.1 Historical Trend (2017-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Diabetes
8.6.2.1 Historical Trend (2017-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Oncology
8.6.3.1 Historical Trend (2017-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Cardiology
8.6.4.1 Historical Trend (2017-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Drug Testing/Pharmacogenomics
8.6.5.1 Historical Trend (2017-2023)
8.6.5.2 Forecast Trend (2024-2032)
8.6.6 HIV/Aids
8.6.6.1 Historical Trend (2017-2023)
8.6.6.2 Forecast Trend (2024-2032)
8.6.7 Autoimmune Diseases
8.6.7.1 Historical Trend (2017-2023)
8.6.7.2 Forecast Trend (2024-2032)
8.6.8 Nephrology
8.6.8.1 Historical Trend (2017-2023)
8.6.8.2 Forecast Trend (2024-2032)
8.6.9 Others
8.7 Latin America In-Vitro Diagnostics Market by End Use
8.7.1 Hospital and Clinics
8.7.1.1 Historical Trend (2017-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Diagnostic Laboratories
8.7.2.1 Historical Trend (2017-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Point-Of-Care Testing
8.7.3.1 Historical Trend (2017-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Academic Institutes
8.7.4.1 Historical Trend (2017-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Others
8.8 Latin America In-Vitro Diagnostics Market by Country
8.8.1 Brazil
8.8.2 Argentina
8.8.3 Mexico
8.8.4 Chile
8.8.5 Peru
8.8.6 Uruguay
8.8.7 Others
9 Regional Analysis
9.1 Brazil
9.1.1 Historical Trend (2017-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Argentina
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 Mexico
9.3.1 Historical Trend (2017-2023)
9.3.2 Forecast Trend (2024-2032)
9.4 Chile
9.4.1 Historical Trend (2017-2023)
9.4.2 Forecast Trend (2024-2032)
9.5 Peru
9.5.1 Historical Trend (2017-2023)
9.5.2 Forecast Trend (2024-2032)
9.6 Uruguay
9.6.1 Historical Trend (2017-2023)
9.6.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 F. Hoffmann-La Roche Ltd
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Becton, Dickinson and Company
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Bio-Rad Laboratories, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 bioMérieux SA
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 WAMA Diagnóstica
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Latin America In-Vitro Diagnostics Market: Key Industry Highlights, 2017 and 2032
2. Latin America In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2017-2023
3. Latin America In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2024-2032
4. Latin America In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2017-2023
5. Latin America In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
6. Latin America In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2017-2023
7. Latin America In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2024-2032
8. Latin America In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2017-2023
9. Latin America In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
10. Latin America In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2023
11. Latin America In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Latin America In-Vitro Diagnostics Market Structure.
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 17.9% between 2024 and 2032.
The major drivers of the market include the rising levels of income, rising standards of living, growing population, government insurance, newly insured patients, and modernised healthcare facilities.
Advancements in technology and demand for quality medical care are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Europe, Latin America, Asia Pacific, the Middle East and Africa, among others.
The various products and services in the Latin America in-vitro diagnostics market are reagents and kits, instruments, software and services.
Based on technology, the market is segmented into infectious disease, clinical chemistry, molecular diagnostics, haematology, microbiology, coagulation and haemostasis, and urinalysis, among others.
The major applications of the market are infectious diseases, diabetes, cardiology, oncology, drug testing/pharmacogenomics, HIV/Aids, autoimmune diseases, and nephrology, among others.
The end-uses of the market are hospital and clinics, diagnostic laboratories, point-of-care testing, and academic institutes, among others.
The major players in the Latin America in-vitro diagnostics market are F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, and WAMA Diagnóstica, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER